New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Keros Therapeutics, Inc.
KROS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

425M

Biotechnology

Next Earning date - 26 Feb 2025

425M

Biotechnology

Next Earning date - 26 Feb 2025

10.49USD

Shape-0.37Ā ( -3.41%)
sun-fogPre-market 10.98$arrow-right-up0.48 (4.62%)
Market Closed (as of Feb 11, 00:33 EDT)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

-22%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

86%

Quote Panel

Shape
Updated February 11, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

KROS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

Shape889%

2025-Revenue

$4.83

Shape-229%

2025-EPS

$768K

Shape99%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Guggenheim

downgrade

Previous: Buy

2024-12-16

Now: Neutral

Jefferies

initialise

Previous: Not converted

2024-11-05

Now: Buy

Cantor Fitzgerald

initialise

Previous: Not converted

2024-10-24

Now: Overweight

Guggenheim

initialise

Previous: Not converted

2024-09-23

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Sales GrowthShape

status-upYoY

Current

Estimates

Return on EquityShape

status-upQoQ

Institutionnal OwnershipShape

status-upQoQ

Earnings Growth

Latest News